High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types
- PMID: 20008660
- DOI: 10.1001/archneurol.2009.285
High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types
Abstract
Background: Supported by compelling genetic data regarding early-onset familial Alzheimer disease (AD), the amyloid beta-peptide (Abeta)-centric theory holds that Abeta is involved in the pathogenesis of sporadic AD. Mutations in the amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) genes lead to increased Abeta levels before symptoms arise.
Objectives: To evaluate the pattern of Pittsburgh Compound B (PiB) retention in subjects with different autosomal dominant mutations associated with familial AD vs that in healthy age-matched control subjects and subjects with probable sporadic AD, to correlate Abeta burden as measured by PiB with available clinical and cognitive data, and to compare the regional brain patterns of PiB retention and fluorodeoxyglucose F 18 (FDG) uptake.
Design: Correlation analysis of positron emission tomography (PET) imaging studies.
Setting: Academic research.
Participants: Seven PSEN1 mutation carriers and 1 APP mutation carrier underwent PiB and FDG PET imaging. Amyloid beta-peptide burden and FDG uptake were established using standardized uptake values normalized to pons.
Main outcome measure: Primary outcomes were PET results, which were compared with those of a well-characterized cohort of 30 healthy control subjects and 30 subjects with probable sporadic AD.
Results: All mutation carriers had high PiB retention in the striatum, with some also having cortical PiB retention in ventrofrontal and posterior cingulate/precuneus areas. The striatal pattern of PiB retention was similar in the PSEN1 and APP mutation carriers. Neither striatal nor cortical Abeta burden was related to cognitive status.
Conclusions: Consistent with previous studies, the pattern of Abeta deposition in familial AD differs from that in sporadic AD, with higher striatal and somewhat lower cortical PiB retention in familial AD. The pattern and degree of Abeta deposition were not associated with mutation type nor cognitive status.
Similar articles
-
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.Neurology. 2012 Jul 17;79(3):229-36. doi: 10.1212/WNL.0b013e31825fdf18. Epub 2012 Jun 13. Neurology. 2012. PMID: 22700814
-
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.J Neurosci. 2007 Jun 6;27(23):6174-84. doi: 10.1523/JNEUROSCI.0730-07.2007. J Neurosci. 2007. PMID: 17553989 Free PMC article.
-
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.Brain. 2016 Mar;139(Pt 3):922-36. doi: 10.1093/brain/awv404. Epub 2016 Jan 26. Brain. 2016. PMID: 26813969 Free PMC article.
-
Alzheimer's disease: genetic basis and amyloid imaging as endophenotype.Q J Nucl Med Mol Imaging. 2011 Jun;55(3):225-36. Q J Nucl Med Mol Imaging. 2011. PMID: 21532537 Review.
-
Genomics of Alzheimer Disease: A Review.JAMA Neurol. 2016 Jul 1;73(7):867-74. doi: 10.1001/jamaneurol.2016.0301. JAMA Neurol. 2016. PMID: 27135718 Free PMC article. Review.
Cited by
-
When Does Alzheimer's Disease Really Start? The Role of Biomarkers.Int J Mol Sci. 2019 Nov 6;20(22):5536. doi: 10.3390/ijms20225536. Int J Mol Sci. 2019. PMID: 31698826 Free PMC article. Review.
-
PET staging of amyloidosis using striatum.Alzheimers Dement. 2018 Oct;14(10):1281-1292. doi: 10.1016/j.jalz.2018.04.011. Epub 2018 May 21. Alzheimers Dement. 2018. PMID: 29792874 Free PMC article.
-
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.Neurology. 2011 Dec 6;77(23):2034-42. doi: 10.1212/WNL.0b013e31823b9c5e. Epub 2011 Nov 30. Neurology. 2011. PMID: 22131541 Free PMC article.
-
Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease.Aust N Z J Psychiatry. 2012 Dec;46(12):1145-58. doi: 10.1177/0004867412457224. Epub 2012 Sep 18. Aust N Z J Psychiatry. 2012. PMID: 22990433 Free PMC article.
-
Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.Lancet Neurol. 2015 Aug;14(8):804-813. doi: 10.1016/S1474-4422(15)00135-0. Epub 2015 Jun 29. Lancet Neurol. 2015. PMID: 26139022 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical